Review
Copyright ©The Author(s) 2016.
World J Transplant. Sep 24, 2016; 6(3): 460-471
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.460
Table 3 Management of Cryptosporidium infections
Ref.Treatment regimen (length)Changes in immunosuppressionResolution of symptomsGraft lossDeath
Abdo et al[15]Rifampin (3 wk)Temporary lower level of TACResolvedNoNo
Acikgoz et al[23]Spiramycin + NTZ + PAR (4 wk)Switch from MMF to AZAResolvedNoNo
Arslan et al[10]N/AN/AN/AN/AN/A
Bandin et al[8]NTZ (4 wk) (2) NTZ (2 wk) (5)1MMF switched to AZA (3)1 MMF reduced (3)1 TAC switched to sirolimus (1)1ResolvedNoNo
Bhadauria et al[3]NTZ (13) (16-60 d) NTZ + fluoroquinolone (21) (16-60 d)MMF → AZA (3) TAC → CsA (8) Reduction of immunosuppression (11)Resolved microbiologically (83%)Yes (3)
Bonatti et al[5]AZM (14-21 d) (2)1 AZM + NTZ (6-18 d) (2)1 NTZ (14-16 d) (2)1 AZM (5 d) + NTZ + TMP/SMX (14 d) (1)1 AZM + PAR(14d) (1)1MMF stopped (4)1 MMF reduced (1)1ResolvedNoNo
Campos et al[18]Spiramycin → PAR (6 mo) PAR(2)N/AResolvedNoNo
Chieffi et al[30]N/AN/AN/AN/AN/A
Clifford et al[21]N/AN/AResolvedNoNo
Delis et al[16]AZM (7 d) + PAR (21 d) (2)1 PAR (14 d) (1)1 PAR (21 d) (1)1Stopped (1/4)1 TAC reduced (1/4)1ResolvedNoNo
Franco et al[100]Spiramicin 10 dMMF → Aza Stopped AzaResolvedNoNo
Frei et al[6]PAR (4 wk)NoResolvedNoNo
Gerber et al[17]AZM (3 wk) (1)1 PAR (2-3 wk) (2)1NoResolvedNoNo
Hong et al[9]NTZ (4 wk) PAR + AZM (5 wk), oral human immunoglobulin (5 d)TAC reduced MMF stopped and AZT startedResolvedNoNo
Krause et al[4]NTZ (5-24 d)NoResolvedNoNo
Ok et al[19]N/AN/AN/AN/AN/A
Pozio et al[14]AZM (1 wk) + PAR (3 wk) AZM + PAR (1 yr 7 mo)N/AResolvedNoNo
Rodríguez Ferrero et al[7]AZM + PAR (14 d) NTZ (6 d)MMF and TAC reducedResolvedNoNo
Tran et al[12]PAR (4 wk)Sirolimus discontinuedResolvedNoNo
Udgiri et al[13]Spiramycin (10 d) (2)1NoResolvedNoNo
Vajro et al[24]NoneNoResolvedNoNo
Ziring et al[11]PAR + AZMN/AResolvedNoNo